Interviews

Download PDF

Register to download the report. Already a member?

 
 
Sign Up

Or

59459 1490631916HCLSReviewIrelandMarch2017.pdf
Energy Boardroom

Pharma Interviews


Filter

SONY DSC

Interview: Peter Gmünder – CEO, Bioforce AG, Switzerland

With a recent clinical trial showing one of Bioforce’s Echinacea products to be non-inferior to the gold standard allopathic treatment Tamiflu, CEO Peter Gmünder is working to continue the work of Swiss phytopharmaceuticals pioneer Alfred Vogel by providing the highest …

28.03.2017

PastedGraphic-8

Interview: Juerg Zuercher – EMEIA Biotech Leader & Partner, EY Switzerland

EY’s Biotech Team Leader for the EMEIA region discusses the challenges Europe’s fragmented capital markets pose for biotech startups, the under-communicated benefits of doing an IPO on the Swiss stock exchange and the implications of the Actelion acquisition for the …

28.03.2017


Fabienne Le Tadic - Executive President Product and Brand Protection - S...

Interview: Fabienne Le Tadic – Executive President, Product and Brand Protection, SICPA, Switzerland

“Robust solutions, the capability to implement them and the ability to do so globally” – The executive president of product and brand protection solutions at SICPA explains why the company is the right partner for companies in the pharmaceutical, healthcare …

28.03.2017

Untitled

Interview: Seref Gültabak – Area Sales Manager, Bosch Packaging Systems AG, Switzerland

With new scalable, flexible, and modular packaging systems soon to be launched commercially, Bosch Packaging Systems is poised to increase its footprint within the pharma industry with a range of automated packaging solutions. To begin, could you please introduce Bosch …

28.03.2017


1

Interview: Guillaume Corpart – Founder & Managing Director, Global Health Intelligence, Mexico

The founder and Managing Director of Global Health Intelligence (GHI), Guillaume Corpart highlights the value of competitive intelligence for medical device companies looking to either enter emerging healthcare markets in Latin America and Asia or identify new market opportunities. As …

24.03.2017

Mark Griffiths -Global CEO - Dishman Groug

Interview: Mark Griffiths – Group CEO, Dishman Group

“Get it done! That is what CARBOGEN AMCIS is all about!” – The CEO of the Swiss drug development and commercialization services company elaborates on the company’s strong mindset and declares customer intimacy to be their unique selling point. CARBOGEN …

24.03.2017


1

Interview: Aristides Torres – CEO, Laboratorios Vanquish, Mexico

Aristides Torres, CEO at Laboratorios Vanquish, explains how the company has evolved during the last five years to serve both the public and private markets and why they have focused on niche market areas with high unmet patient need. Could …

24.03.2017

1

Interview: Jui-Lin Chen PhD – CEO, MiCareo, Taiwan

Jui-Lin Chen, CEO of MiCareo, provides insights into the development of MiSelect, Micareo’s pioneering platform for the analysis of Circulating Tumor Cells (CTC) and other rare cells, which proudly stands as the best product available to physicians for cancer prognosis …

24.03.2017


Untitled

Interview: Sergio Olivares – Managing Director, Olivares, Mexico

Sergio Olivares, managing director at Olivares, explains the TPP’s impact on the Mexican pharmaceutical industry’s dynamism and Olivares’ business proposal as a one-stop shop solution to fulfill all its current and future clients’ intellectual property needs. Olivares began as an …

23.03.2017

Untitled

Interview: Raymond Cron – CEO, Switzerland Innovation

The most innovative country in the world must constantly launch new initiatives to attract R&D activities if that lead is to be maintained, and Switzerland Innovation is doing just that – by showcasing the opportunities that the Swiss Innovation Park …

23.03.2017


1

Interview: Mario Amadio – President & CEO, GE Healthcare Mexico

“Equipment is not everything that GE can contribute with!” – The CEO and President of GE Healthcare’s Mexican Unit elaborates on how GE provides added value to its customers by focusing on innovating access, cost and quality. With what mission …

23.03.2017

Thomas Bohn - GGBa

Interview: Thomas Bohn – Executive Director, Greater Geneva Bern area (GGBa), Switzerland

The Executive Director of the Greater Geneva Bern area, Western Switzerland’s investment promotion agency, elaborates on the unique assets the region has to offer, and highlights the strong pro-business mindset of the Swiss people. Could you please start by elaborating …

23.03.2017


Cover_HCLS_Ireland LATEST ISSUE

DOWNLOAD

X
Download PDF

First Name:

Last Name:

Company:

Position:

Country:

Email: